Stay updated on Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial

Sign up to get notified when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Footer revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:45:11.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision changed from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:53:41.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision label changed from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T16:27:33.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page now shows a new revision banner 'Revision: v3.4.2' and removes older funding/operating notices. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:00:03.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and updated the page revision to v3.4.1; removed the previous v3.4.0 revision. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:23:50.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a glossary toggle, updated the QC status to 'Last Update Submitted that Met QC Criteria', and added 'No FEAR Act Data' and 'Revision: v3.4.0'. Removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-27T23:48:36.000Z thumbnail image

Stay in the know with updates to Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.